Table 3:
Trial characteristics* | Adjusted OR (95% Confidence Interval) | p-value |
---|---|---|
Publication year | 0.289 | |
2014 – 2015 | Ref | |
2016 – 2017 | 1.05 (0.68 to 1.61) | 0.835 |
2018 – 2019 | 0.73 (0.45 to 1.19) | 0.209 |
Journal impact factor | 0.001 | |
Tertile 1: [0.11 – 3.575) | Ref | |
Tertile 2: [3.575 – 7.958) | 1.34 (0.88 – 2.05) | 0.168 |
Tertile 3: [7.958 – 70.67] | 0.53 (0.32 – 0.88) | 0.015 |
Design | <0.0001 | |
Individually randomised trial | Ref | |
CRT with no professional-level or cluster-level interventions | 1.58 (0.84 – 2.97) | 0.156 |
CRT with professional-level intervention, possibly other interventions, no cluster-level interventions | 7.84 (4.68 – 13.12) | <0.0001 |
CRT with at least some cluster-level interventions | 5.25 (3.30 – 8.34) | <0.0001 |
Country of corresponding author | 0.213 | |
LMIC only | Ref | |
Other | 0.47 (0.16 to 1.42) | 0.183 |
EU only or UK only | 1.24 (0.60 to 2.56) | 0.561 |
Canada only or US only | 1.26 (0.64 to 2.47) | 0.508 |
Setting | 0.152 | |
Clinical | Ref | |
Public health | 0.70 (0.43 – 1.14) | 0.152 |
Self-identified as pragmatic | 0.249 | |
No | Ref | |
Yes | 1.29 (0.84 – 1.99) | 0.249 |
Only pre-specified characteristics were entered into the model.
CRT = Cluster randomised trial